• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC.

作者信息

Khan Sohini, Baumgartner Joel M

机构信息

Division of Surgical Oncology, Department of Surgery, University of California San Diego, 3855 Health Sciences Dr. #0987, La Jolla, CA, 92093-0987, USA.

出版信息

Ann Surg Oncol. 2023 Feb;30(2):774-775. doi: 10.1245/s10434-022-12775-8. Epub 2022 Nov 11.

DOI:10.1245/s10434-022-12775-8
PMID:36367628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9807545/
Abstract
摘要

相似文献

1
ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC.ASO作者反思：减瘤手术和热灌注化疗期间的常规大网膜切除术
Ann Surg Oncol. 2023 Feb;30(2):774-775. doi: 10.1245/s10434-022-12775-8. Epub 2022 Nov 11.
2
ASO Author Reflections: Thirty Years of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Wake Forest University.ASO作者反思：维克森林大学开展热灌注化疗（HIPEC）联合重复细胞减灭术三十年
Ann Surg Oncol. 2022 Jun;29(6):3446-3447. doi: 10.1245/s10434-022-11514-3. Epub 2022 Mar 11.
3
ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis.ASO作者反思：减瘤手术联合腹腔热灌注化疗治疗伴腹膜转移的胃癌：一项系统评价和荟萃分析
Ann Surg Oncol. 2022 Nov;29(12):7538-7539. doi: 10.1245/s10434-022-12317-2. Epub 2022 Jul 30.
4
ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis.ASO作者反思：全身化疗对接受减瘤手术和热灌注化疗（HIPEC）治疗的结直肠癌腹膜转移患者是否有用？一项倾向评分分析。
Ann Surg Oncol. 2024 Mar;31(3):2008-2009. doi: 10.1245/s10434-023-14468-2. Epub 2023 Oct 18.
5
ASO Author Reflections: Decoding the Complexities of Cytoreductive Surgery and HIPEC Procedural Billing: A Potential Blueprint for the Peritoneal Surface Malignancy Surgeon.美国外科医师学会作者反思：解读细胞减灭术和腹腔热灌注化疗手术计费的复杂性：为腹膜表面恶性肿瘤外科医生提供的潜在蓝图。
Ann Surg Oncol. 2024 Mar;31(3):2012-2013. doi: 10.1245/s10434-023-14582-1. Epub 2023 Nov 19.
6
ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).ASO作者反思：微卫星和RAS/RAF突变状态作为接受减瘤手术和腹腔内热灌注化疗（HIPEC）治疗的结直肠癌腹膜转移的预后因素
Ann Surg Oncol. 2022 Jun;29(6):3418-3419. doi: 10.1245/s10434-021-11057-z. Epub 2021 Nov 6.
7
ASO Author Reflections: Characterizing the Peritoneal Immune Response to the Surgical and Thermal Trauma of Peritoneal Cytoreduction and HIPEC.ASO作者反思：表征腹膜对减瘤术和热灌注化疗的手术及热损伤的免疫反应。
Ann Surg Oncol. 2020 Dec;27(13):5014-5015. doi: 10.1245/s10434-020-08943-3. Epub 2020 Jul 27.
8
ASO Author Reflections: Disparate Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Based on Insurance Status.ASO作者反思：基于保险状况的减瘤手术联合热灌注化疗后的不同结局
Ann Surg Oncol. 2022 Jan;29(1):260-261. doi: 10.1245/s10434-021-10748-x. Epub 2021 Aug 28.
9
ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning Algorithms.ASO作者反思：通过传统算法和机器学习算法，利用腹腔热灌注化疗增强减瘤手术周围的临床决策制定。
Ann Surg Oncol. 2023 Sep;30(9):5443-5444. doi: 10.1245/s10434-023-13716-9. Epub 2023 Jun 2.
10
ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：原发性肿瘤位置和基因组改变在结直肠癌腹膜转移及细胞减灭术-热灌注化疗中的意义
Ann Surg Oncol. 2023 Jul;30(7):4471-4472. doi: 10.1245/s10434-023-13522-3. Epub 2023 Apr 27.

本文引用的文献

1
Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?常规网膜切除术是否是细胞减灭术和 HIPEC 的必要组成部分？
Ann Surg Oncol. 2023 Feb;30(2):768-773. doi: 10.1245/s10434-022-12714-7. Epub 2022 Oct 28.
2
Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review.结直肠癌腹膜转移的临床研究：试验、困境及未来方向——一项系统评价
J Surg Oncol. 2018 Feb;117(2):245-259. doi: 10.1002/jso.24813. Epub 2017 Nov 9.
3
Recent insights into the pathophysiology of omental metastases.对网膜转移病理生理学的最新见解。
J Surg Oncol. 2014 Nov;110(6):670-5. doi: 10.1002/jso.23681. Epub 2014 Jun 24.
4
Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth.腹膜肿瘤转移灶对网膜免疫聚集体的优先附着以及独特血管微环境在转移灶存活和生长中的可能作用。
Am J Pathol. 2006 Nov;169(5):1739-52. doi: 10.2353/ajpath.2006.051222.